Alivus Life Sciences Limited: insider trading, SAST and pledges

No insider-trading filing for this company in the last two years.

FiledPersonCategoryTypeModeQuantityValueHolding after
15 Jul 2024 GLENN SALDANHAPromoter group Sell Others 0 ₹0 0.00%
from 0.01%
15 Jul 2024 Glenmark Pharmaceutical LimitedPromoter Sell Others 0 ₹0 0.00%
from 7.84%
13 Mar 2024 Glenmark Pharmaceutical LimitedPromoter Sell Off Market 0 ₹0 7.84%
from 27.84%
13 Mar 2024 Nirma LimitedPromoter Buy Off Market 0 ₹0 75.00%
from 55.00%
7 Mar 2024 Glenmark Pharmaceuticals LimitedPromoter Sell Off Market 0 ₹0 27.84%
from 82.84%
25 Sep 2023 Glenmark Pharmaceuticals LimitedPromoter Pledge Others 0 ₹590.99 Cr 82.84%
from 82.84%
17 Nov 2021 GLENN SALDANHAPromoter group Buy Market Purchase 0 ₹0 0.00%
from 0.00%
17 Nov 2021 GLENN SALDANHAPromoter group Buy Market Purchase 0 ₹0 0.00%
from 0.00%
Page 1 of 1

Disclosures are shown as filed with the exchanges; Tradinity does not verify them. Nothing here is investment advice.